Dubai Ruler dances with joy after Thunder Snow wins Dubai World Cup

Khaleej Times
April 1, 2018

Dubai may have been hot and humid over the past week but thunder and snow rained on the city on Saturday night.

And the royal blue silks, the colours of Godolphin, hung over the spectacular Meydan Racecourse as Thunder Snow won the 23rd renewal of the $10 million Dubai World Cup.

The four-year-old bay colt from Helmet, the mount of Christophe Soumillon, ended Emirati handler Saeed bin Suroor's two-year drought, in sensational style, winning the 10-furlong affair by a comprehensive five-and-three-quarter of a length over strong favourite, the USA's West Coast.

Thunder Snow aced the five-horse American challenge to win in record time, putting Arrogate's 2:02:53 seconds to shade with a time of 2:01:38 seconds.

It was Thunder Snow's seventh win in 18 starts but the biggest Group 1 victory of his fledging career. The win also increased Saeed bin Suroor's tally to an astonishing record eight at the Dubai World Cup, the most by any trainer.

Thunder Snow's victory also brought up Suroor's 38th win after Benbatl had triumphed in the Dubai Turf earlier on the night.

And while Thunder Snow, Godolphin and Saeed bin Suroor all racked up the numbers, it was a life-long dream becoming a reality for Christophe Soumillon.

The Belgian jockey notched his first Dubai World Cup in nine attempts. The 36-year-old's best result was the runner-up finish to California Chrome, on board Mubtaahij.

Thunder Snow was drawn on an unfavourable Gate 10, right on the outside, but that didn't deter him as it was to be his night.

Thunder Snow was out of the gates in a blink of an eye and with North America, his UAE rival, with whom he tussled in the Al Maktoum Challenge, missing the start, it made it all the more easier. But it was just one contender down and many more to go as the Americans lurked. Thunder Snow still had a job to do and he did it in some style.

He kept West Coast, with whom he had exchanged the lead briefly at the start, at bay over the course of the 2000-metre contest. And Thunder Snow then went on to deny American legendary trainer Bob Baffert a second win on the trot and a fourth at the World Cup.

"We won two years in a row and now we have come back and won it again. It is a great and a brilliant result," an elated Saeed bin Suroor said, moments after the race.

"The jockey did a great job despite being drawn from Gate 10. What he has done, nobody has done. To take Thunder Snow from the Gate 10 and to take him to a position from where he can win is superb," added the Emirati, whose last win came with Prince Bishop, ridden by William Buick.

Meanwhile, Soumillon revealed that a pre-race pep talk helped him win. "I don't know if it was Sheikh Mohammed's daughter, a little girl, she told me: 'It is small track and if you go in front then, you are going to win it.' I never thought I can do that running with that draw. He jumped quite well and I saw nobody trying to challenge me and then West Coast let me go. And when I arrived at the first corner, my horse was in front and, on the back straight, I was just cantering. He is a very funny horse and very talented but when he doesn't want to do, he doesn't and when he wants, it is just amazing. He was in great shape and pretty fit. He has shown that in Europe and last year in Kentucky.

"It is difficult to say how I'm feeling because it has not sunk in. I had finished second one time but winning this was like a dream come true," said Soumillon.

SOUMILLON'S FIRST
2010: 11 on Red Desire (Mikio Matsunaga), won by Gloria De Campeo

2011: 7 on Musir (Mike de Kock), won by Victoire Pisa

2012: 8 on Master Of Hounds (Mike de Kock), won by Monterosso

2013: 8 on Treasure Beach (Mike de Kock), won by Animal Kingdom

2014: 7 on Sanshaawes (Mike de Kock), won by African Story

2015: 9 on Epiphaneia (Katsuhiko Sumii), won by Prince Bishop

2016: 2 on Mubtaahij (Mike de Kock), won by California Chrome

2017: 4 on Mubtaahij (Mike de Kock), won by Arrogate

2018: Winner on Thunder Snow (Saeed bin Suroor)

Comments

angel of death
 - 
Monday, 2 Apr 2018

Allah given Power to these ARAB scumbags for the upliftment of muslim world but they dance as per western tune. 

 

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 1,2020

New Delhi, Jan 1: Prevention of Money Laundering Act (PMLA) court in Mumbai has allowed banks that lent money to embattled liquor tycoon Vijay Mallya to utilize seized assets, news agency reported today quoting sources from the Enforcement Directorate (ED). The court also said all parties affected by the order can appeal at the Bombay High Court till January 18.

Last month, a consortium of Indian banks petitioned a London court for ex-billionaire Vijay Mallya to be declared bankrupt over ₹9,000 crore in unpaid debts. It comes as Mallya, who founded the now defunct Kingfisher Airlines Ltd, faces extradition to his home country of India.

Mallya had fled India in March 2016 and has been living in the United Kingdom since then. The 64-year-old former Kingfisher Airlines is fighting extradition to India in relation of fraud and money laundering allegations arising out of the debt acquired from the banks.

Mallya remains on bail pending the UK High Court appeal hearing in the extradition proceedings brought by India in relation to fraud and money laundering charges amounting to ₹9,000 crores. He had been arrested on an extradition warrant back in April 2017 and has been fighting his extradition in the UK courts since then.

He was granted permission to appeal against his extradition order, which is scheduled in the Royal Courts of Justice in London for February.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Nerwork
June 7,2020

New Delhi, Jun 7: Rain lashed some parts of the Delhi-NCR on Sunday morning.

The India Meteorological Department (IMD) has predicted partly cloudy sky with possibility of development of thunder lightning for three days from June 10 onwards with minimum and maximum temperature will hover around 29° Celcius and 42° Celcius respectively.

Strong surface winds during day time have been predicted for today by IMD.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.